Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy—Kynurenines Are Important Players
Open Access
- 5 June 2021
- Vol. 26 (11), 3423
- https://doi.org/10.3390/molecules26113423
Abstract
Neurodegeneration is one of the driving forces behind the pathogenesis of multiple sclerosis (MS). Progression without activity, pathopsychological disturbances (cognitive impairment, depression, fatigue) and even optic neuropathy seems to be mainly routed in this mechanism. In this article, we aim to give a comprehensive review of the clinical aspects and symptomology, radiological and molecular markers and potential therapeutic targets of neurodegeneration in connection with MS. As the kynurenine pathway (KP) was evidenced to play an important role in the pathogenesis of other neurodegenerative conditions (even implied to have a causative role in some of these diseases) and more and more recent evidence suggest the same central role in the neurodegenerative processes of MS as well, we pay special attention to the KP. Metabolites of the pathway are researched as biomarkers of the disease and new, promising data arising from clinical evaluations show the possible therapeutic capability of KP metabolites as neuroprotective drugs in MS. Our conclusion is that the kynurenine pathway is a highly important route of research both for diagnostic and for therapeutic values and is expected to yield concrete results for everyday medicine in the future.This publication has 228 references indexed in Scilit:
- The Peroxisome Proliferator-activated Receptor γ (PPARγ) Controls Natural Protective Mechanisms against Lipid Peroxidation in Amyotrophic Lateral Sclerosis*Online Journal of Public Health Informatics, 2012
- Inflammation-Related Disorders in the Tryptophan Catabolite Pathway in Depression and SomatizationAdvances in Protein Chemistry and Structural Biology, 2012
- Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates NeurodegenerationCell, 2011
- Interferon-gamma-inducible kynurenines/pteridines inflammation cascade: implications for aging and aging-associated psychiatric and medical disordersJournal of Neural Transmission, 2010
- Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytesGlia, 2010
- Inflammation induced by innate immunity in the central nervous system leads to primary astrocyte dysfunction followed by demyelinationActa Neuropathologica, 2010
- Evidence for a two-stage disability progression in multiple sclerosisBrain, 2010
- Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte deathBrain, 2010
- The nuclear receptor PPARγ selectively inhibits Th17 differentiation in a T cell–intrinsic fashion and suppresses CNS autoimmunityThe Journal of Experimental Medicine, 2009
- Mitochondrial changes within axons in multiple sclerosisBrain, 2009